iconEarnings Announcement After Market Close

FibroGen Inc FGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
14.60UNCH (UNCH)
Volume
55,638
Close
14.60quote price arrow up+0.09 (+0.62%)
Volume
460,476
52 week range
7.81 - 16.91
Loading...
  • Open14.53
  • Day High14.65
  • Day Low14.05
  • Prev Close14.51
  • 52 Week High16.91
  • 52 Week High Date02/09/22
  • 52 Week Low7.81
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap1.362B
  • Shares Out93.30M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.89
  • YTD % Change3.55

KEY STATS

  • Open14.53
  • Day High14.65
  • Day Low14.05
  • Prev Close14.51
  • 52 Week High16.91
  • 52 Week High Date02/09/22
  • 52 Week Low7.81
  • 52 Week Low Date05/09/22
  • Market Cap1.362B
  • Shares Out93.30M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.89
  • YTD % Change3.55

RATIOS/PROFITABILITY

  • EPS (TTM)-3.04
  • P/E (TTM)-4.80
  • Fwd P/E (NTM)-4.19
  • EBITDA (TTM)-269.011M
  • ROE (TTM)-106.41%
  • Revenue (TTM)257.71M
  • Gross Margin (TTM)94.68%
  • Net Margin (TTM)-109.83%
  • Debt To Equity (MRQ)10.99%

EVENTS

  • Earnings Date08/08/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On FibroGen Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
FibroGen, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing a pipeline of therapeutics. It applies its capabilities in hypoxia-inducible factor (HIF) biology, 2-oxoglutarate enzymology, and connective tissue growth factor (CTGF) biology to advance medicines for the treatment of anemia, fibrotic disease, and cancer. The Company’s product Roxadustat is an oral small molecule inhibitor of HIF-prolyl hydroxylase activity...
James Schoeneck
Independent Chairman of the Board
Enrique Conterno
Chief Executive Officer, Director
Juan Graham
Chief Financial Officer
Address
409 ILLINOIS STREET
San Francisco, CA
94158
United States

Top Peers

SYMBOLLASTCHG%CHG
MYOV
Myovant Sciences Ltd
15.67+0.55+3.64%
LGND
Ligand Pharmaceuticals Inc
99.25+2.12+2.18%
ME
23andMe Holding Co.
3.98+0.34+9.34%
PRTA
Prothena Corporation PLC
33.01-0.10-0.30%
PACB
Pacific Biosciences of California Inc
6.90+0.84+13.86%